Clinical Trials Browser

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

NCT01774721 2023-11-14

ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

Phase 3 Completed

452 enrolled 35 charts 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT01544179 2020-09-25

IMPRESS

Phase 3 Completed

265 enrolled 20 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase 3 Completed

23 enrolled

Thoracic

Lung Neoplasms, Neoplasms

NCT01024413 2017-03-01

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Phase 3 Completed

256 enrolled

Thoracic

Lung Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT01404260 2017-01-27

ISCAN

Phase 3 Completed

219 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00357734 2016-08-30

Iressa Follow-up Trial

Phase 3 Completed

14 enrolled 10 charts

BreastThoracic

Breast Neoplasms, Lung Neoplasms

NCT01017874 2015-07-08

A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

Phase 3 Completed

236 enrolled 15 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00049543 2015-01-01

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

Phase 3 Completed

503 enrolled 12 charts

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT01040780 2014-02-14

ICOGEN

Phase 3 Completed

399 enrolled 12 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00322452 2013-11-07

IPASS

Phase 3 Completed

1,329 enrolled 25 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00020709 2013-02-27

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Phase 3 Completed

840 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00034879 2013-01-04

Iressa Expanded Access Program (EAP)

Phase 3 Completed

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT00478049 2012-06-06

ISTANA

Phase 3 Completed

163 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00807066 2012-04-23

RANGE

Phase 3 Completed

1 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00076388 2011-05-13

Iressa Versus Docetaxel (Taxotere)

Phase 3 Completed

1,440 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00206219 2011-01-27

Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

Phase 3 Completed

477 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00455936 2010-10-25

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Phase 3 Completed

315 enrolled

Thoracic

Adenocarcinoma, Lung Neoplasms

NCT00635973 2009-04-22

Open-Label Extension of Other SZ1839 (Iressa) Trials

Phase 3 Completed

100 enrolled

Tumor-Agnostic

Neoplasms

NCT00080340 2008-01-15

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 3 Completed

520 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00252707 2007-12-18

Iressa 2nd Line Phase III Study in Japan

Phase 3 Completed

484 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00144066 2005-09-02

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Phase 3 Completed

600 enrolled

Thoracic

Lung Neoplasms

Clinical Trials

FLAURA

ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

IMPRESS

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

ISCAN

Iressa Follow-up Trial

A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

ICOGEN

IPASS

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Iressa Expanded Access Program (EAP)

ISTANA

RANGE

Iressa Versus Docetaxel (Taxotere)

Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Open-Label Extension of Other SZ1839 (Iressa) Trials

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Iressa 2nd Line Phase III Study in Japan

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer